The end of balloons? Our take on the UK-REBOA trial

Jostein Rødseth Brede, Marius Rehn, Jostein Rødseth Brede, Marius Rehn

Abstract

Background: Resuscitative endovascular balloon occlusion of the aorta (REBOA) is increasingly used. The recently published UK-REBOA trial aimed to investigate patients suffering haemorrhagic shock and randomized to standard care alone or REBOA as adjunct to standard care and concludes that REBOA may increase the mortality.

Main body: In this commentary we try to balance the discussion on use of REBOA and address limitations in the UK-REBOA trial that may have influenced the outcome of the study.

Conclusion: The situation is complex, and the patients are in extremis. In summary, we do not think this is the end of balloons.

Keywords: Aortic occlusion; Non-compressible haemorrhage; REBOA; Resuscitative endovascular balloon occlusion of the aorta; UK-REBOA trial.

Conflict of interest statement

The authors declare that they have no financial competing interest. JRB and MR are both involved in REBOA research in cardiac arrest. Both authors are partially employed in the Norwegian Air Ambulance Foundation for research purposes.

© 2023. The Author(s).

References

    1. Brenner M, Bulger EM, Perina DG, Henry S, Kang CS, Rotondo MF, et al. Joint statement from the American College of Surgeons Committee on Trauma (ACS COT) and the American College of Emergency Physicians (ACEP) regarding the clinical use of Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) Trauma Surg Acute Care Open. 2018;3(1):154.
    1. RibeiroJunior MAF, Feng CYD, Nguyen ATM, Rodrigues VC, Bechara GEK, de-Moura RR, et al. The complications associated with Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) World J Emerg Surg. 2018;13(1):20. doi: 10.1186/s13017-018-0181-6.
    1. Joseph B, Zeeshan M, Sakran JV, Hamidi M, Kulvatunyou N, Khan M, et al. Nationwide analysis of resuscitative endovascular balloon occlusion of the aorta in civilian trauma. JAMA Surg. 2019;154(6):500–8. doi: 10.1001/jamasurg.2019.0096.
    1. Jansen JO, Hudson J, Cochran C, MacLennan G, Lendrum R, Sadek S, et al. Emergency Department resuscitative endovascular balloon occlusion of the aorta in trauma patients with exsanguinating hemorrhage: the UK-REBOA randomized clinical trial. JAMA. 2023 doi: 10.1001/jama.2023.20850.
    1. Karim Brohi [@karimbrohi]. UK-REBOA results: REBOA increased mortality at 90 days and at all interim time points. REBOA increased deaths due to bleeding at 3 hours and 90 days. REBOA substantially delayed time to definitive haemorrhage control. #ccr23 [Internet]. Twitter. 2023 [cited 18 September 2023]. Tilgjengelig på: .
    1. Qasim Z. JC: the UK-REBOA trial. Has the balloon popped? St Emlyn’s [Internet]. St. Emlyn’s. 2023 [cited 18 September 2023]. .
    1. Roy J. Front line medical technologies; 2023 [cited 16 October 2023]. SPOTLIGHT: the UK REBOA Trial: too many questions, not enough answers—Frontline. .
    1. Tisherman SA, Brenner ML. Contemporary adjuncts to hemorrhage control. JAMA. 2023 doi: 10.1001/jama.2023.16135.
    1. Wolthers SA, Jensen TW, Breindahl N, Milling L, Blomberg SN, Andersen LB, et al. Traumatic cardiac arrest—a nationwide Danish study. BMC Emerg Med. 2023;23(1):69. doi: 10.1186/s12873-023-00839-1.
    1. Fleminger S, Ponsford J. Long term outcome after traumatic brain injury. BMJ. 2005;331(7530):1419–1420. doi: 10.1136/bmj.331.7530.1419.
    1. Brede JR, Skjærseth E, Klepstad P, Nordseth T, Krüger AJ. Changes in peripheral arterial blood pressure after resuscitative endovascular balloon occlusion of the aorta (REBOA) in non-traumatic cardiac arrest patients. BMC Emerg Med. 2021;21(1):157. doi: 10.1186/s12873-021-00551-y.
    1. Nozari A, Rubertsson S, Wiklund L. Improved cerebral blood supply and oxygenation by aortic balloon occlusion combined with intra-aortic vasopressin administration during experimental cardiopulmonary resuscitation. Acta Anaesthesiol Scand. 2000;44(10):1209–1219. doi: 10.1034/j.1399-6576.2000.441005.x.
    1. Nozari A, Rubertsson S, Wiklund L. Intra-aortic administration of epinephrine above an aortic balloon occlusion during experimental CPR does not further improve cerebral blood flow and oxygenation. Resuscitation. 2000;44(2):119–127. doi: 10.1016/S0300-9572(00)00132-5.
    1. Nozari A, Rubertsson S, Gedeborg R, Nordgren A, Wiklund L. Maximisation of cerebral blood flow during experimental cardiopulmonary resuscitation does not ameliorate post-resuscitation hypoperfusion. Resuscitation. 1999;40(1):27–35. doi: 10.1016/S0300-9572(99)00003-9.
    1. Gedeborg R, Hans C, Rubertsson S, Wiklund L. Cerebral ischaemia in experimental cardiopulmonary resuscitation—comparison of epinephrine and aortic occlusion. Resuscitation. 2001;50(3):319–29. doi: 10.1016/S0300-9572(01)00350-1.
    1. Rødseth BJ, Thomas L, Pål K, Aardal SE, Trond N, Edmund S. Feasibility of pre-hospital resuscitative endovascular balloon occlusion of the aorta in non-traumatic out-of-hospital cardiac arrest. J Am Heart Assoc. 2019;8(22):e014394. doi: 10.1161/JAHA.119.014394.
    1. Brede JR, Skulberg AK, Rehn M, Thorsen K, Klepstad P, Tylleskär I, et al. REBOARREST, resuscitative endovascular balloon occlusion of the aorta in non-traumatic out-of-hospital cardiac arrest: a study protocol for a randomised, parallel group, clinical multicentre trial. Trials. 2021;22(1):511. doi: 10.1186/s13063-021-05477-1.
    1. Gorman E, Nowak B, Klein M, Inaba K, Morrison J, Scalea T, et al. High resuscitative endovascular balloon occlusion of the aorta procedural volume is associated with improved outcomes: an analysis of the AORTA registry. J Trauma Acute Care Surg. 2021;91(5):781–9. doi: 10.1097/TA.0000000000003201.
    1. Tisherman SA, Schmicker RH, Brasel KJ, Bulger EM, Kerby JD, Minei JP. Detailed description of all deaths in both the shock and traumatic brain injury hypertonic saline trials of the resuscitation outcomes consortium. Ann Surg mars. 2015;261(3):586. doi: 10.1097/SLA.0000000000000837.
    1. Barbosa RR, Rowell SE, Fox EE, Holcomb JB, Bulger EM, Phelan HA, et al. Increasing time to operation is associated with decreased survival in patients with a positive FAST exam requiring emergent laparotomy. J Trauma Acute Care Surg. 2013;75(101):S48–52. doi: 10.1097/TA.0b013e31828fa54e.
    1. Latif RK, Clifford SP, Baker JA, Lenhardt R, Haq MZ, Huang J, et al. Traumatic hemorrhage and chain of survival. Scand J Trauma Resusc Emerg Med. 2023;31(1):25. doi: 10.1186/s13049-023-01088-8.
    1. Brede JR, Søvik E, Rehn M. Resuscitative endovascular balloon occlusion of the aorta: the postpartum haemorrhage perspective. Crit Care. 2022;26(1):57. doi: 10.1186/s13054-022-03942-0.
    1. Godø BN, Brede JR, Krüger AJ. Needs assessment of resuscitative endovascular balloon occlusion of the aorta (REBOA) in patients with major haemorrhage: a cross-sectional study. Emerg Med J. 2022;39(7):521–6. doi: 10.1136/emermed-2020-210808.
    1. Hoehn MR, Hansraj NZ, Pasley AM, Brenner M, Cox SR, Pasley JD, et al. Resuscitative endovascular balloon occlusion of the aorta for non-traumatic intra-abdominal hemorrhage. Eur J Trauma Emerg Surg Off Publ Eur Trauma Soc. 2019;45(4):713–8. doi: 10.1007/s00068-018-0973-0.
    1. Kamijo K, Nakajima M, Shigemi D, Kaszynski RH, Ohbe H, Goto T, et al. Resuscitative endovascular balloon occlusion of the aorta for life-threatening postpartum hemorrhage: a nationwide observational study in Japan. J Trauma Acute Care Surg. 2022;93(3):418–23. doi: 10.1097/TA.0000000000003650.
    1. Stensaeth KH, Sovik E, Haig INY, Skomedal E, Jorgensen A. Fluoroscopy-free Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) for controlling life threatening postpartum hemorrhage. PLoS ONE. 2017;12(3):e0174520. doi: 10.1371/journal.pone.0174520.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren